Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Molybdenum is an essential trace element that functions as a fundamental component of the molybdenum cofactor (Moco), which is indispensable for the catalytic activity of specific human enzymes: sulfite oxidase, xanthine oxidase, aldehyde oxidase, and the mitochondrial amidoxime-reducing component [2, 11, 21]. These enzymes facilitate vital metabolic processes, including the detoxifying conversion of sulfite to sulfate and the final steps of purine catabolism to uric acid [9, 15, 17]. While molybdenum itself is not a traditional therapeutic target such as a receptor or enzyme, its metabolic pathways are critical; genetic defects in Moco biosynthesis result in Molybdenum Cofactor Deficiency (MoCD), a severe neonatal disorder characterized by rapid neurodegeneration and early mortality [4, 6, 18]. Therapeutic strategies for MoCD Type A involve replacement of the missing Moco precursor using drugs like fosdenopterin (Nulibry) [1, 7]. Additionally, molybdenum-containing compounds like ammonium tetrathiomolybdate are utilized clinically as copper chelators to manage Wilson's disease or investigated for anti-angiogenic properties in oncology [13]. High dietary or industrial exposure to molybdenum can disrupt mineral balance, potentially leading to secondary copper deficiency or gout-like symptoms due to excessive uric acid production [2, 14, 16].
Molybdenum serves as a catalytic metal center within the molybdenum cofactor (Moco), facilitating oxygen atom transfer and redox cycling between Mo(IV) and Mo(VI) states in specific metabolic enzymes [11, 18, 22].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Molybdenum (Mo).